Genzyme Seprafilm Admissions Muted In New DOJ Settlement
Genzyme Corp.'s criminal admissions Thursday that its sales representatives helped surgeons modify its Seprafilm adhesion barrier device are tempered compared to previously settled False Claims Act allegations that described direct company...To view the full article, register now.
Already a subscriber? Click here to view full article